Frontier Wealth Management’s iBio IBIO Stock Holding History

Frontier Wealth Management’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20	Closed	-$11K	–	358
2020 Q1	$11K	Buy	+20	New	+$7.7K	﹤0.01%	284

Other funds holding IBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Frontier Wealth Management's IBIO Position: Q2 2020 in Review

Frontier Wealth Management sold out of iBio (IBIO) in Q2 2020, closing a stake of 20 shares — an estimated $11K sold.

Frontier Wealth Management first reported a position in IBIO in Q1 2020 and held it in 1 quarter. The position peaked at $11K in Q1 2020. 57 funds tracked by Wall St. Rank hold IBIO as of Q2 2020.

Frontier Wealth Management reported no remaining iBio position as of Q2 2020 after selling out during the quarter.
Frontier Wealth Management sold 20 iBio shares in Q2 2020, an estimated $11K.
Frontier Wealth Management first reported a position in iBio in Q1 2020 and held it in 1 quarter.
Frontier Wealth Management's iBio position peaked at $11K in Q1 2020.
57 funds tracked by Wall St. Rank held iBio as of Q2 2020.

Based on Frontier Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.